Article
High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus…
Journal of Hepatocellular Carcinoma · 2024 · Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D
Key facts
| Title | High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization |
|---|---|
| First author | Zhang B, Huang B, Yang F, Yang J, Kong M, Wang J, Xiang Y, Wang K, Peng R, Yang K, An C, Yan D |
| Journal | Journal of Hepatocellular Carcinoma |
| Published | Mar 27, 2024 |
| DOI | 10.2147/JHC.S455953 |
| Devices mentioned | 211545 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1